Rebound phenomena: results of a 10 years' (1970--1980) literature review.
A survey of the literature over 10 years (1970--1980) shows that the phenomenon of 'rebound' can appear after withdrawal of a large number of drugs belonging to various chemical classes and also, as a physiologic compensatory mechanism of the central nervous system, without drugs. Among the various drugs, benzodiazepine hypnotics are also mentioned in problems related to 'rebound' (insomnia, anxiety). Controversial opinions are expressed regarding the appearance of rebound insomnia or anxiety. It seems that those authors who believe in the existence of rebound relate it either to therapy with high doses of drugs or to hypnotics with short to intermediate half-life.
D014151:Anti-Anxiety Agents / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D001569:Benzodiazepines; D002317:Cardiovascular Agents / Q000009:adverse effects; D004311:Double-Blind Method; D006728:Hormones / Q000009:adverse effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D001523:Mental Disorders / Q000188:drug therapy; D011619:Psychotropic Drugs / Q000009:adverse effects* / Q000627:therapeutic use; D012894:Sleep Stages / Q000187:drug effects; D013375:Substance Withdrawal Syndrome / Q000209:etiology*
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D002317:Cardiovascular Agents; D006728:Hormones; D006993:Hypnotics and Sedatives; D011619:Psychotropic Drugs; D001569:Benzodiazepines